Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-15-013688
Filing Date
2015-03-06
Accepted
2015-03-06 13:48:10
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 25810
  Complete submission text file 0000000000-15-013688.txt   36677
Mailing Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037
Business Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037 202-734-3400
Vanda Pharmaceuticals Inc. (Filed for) CIK: 0001347178 (see all company filings)

EIN.: 030491827 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2834 Pharmaceutical Preparations